Clinical Trial Update: Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial [Phase 4]

View source ↗

Summary

This document outlines a Phase 4 pragmatic randomized controlled trial evaluating glucagon-like peptide-1 (GLP-1) analogs for disease outcomes in psoriatic arth…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• GLP-1 receptor agonists (unspecified)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Psoriatic Arthritis (PsA) | Phase 4 | Status: NOT_YET_RECRUITING